EuroBiotech: More Articles of Note

newspapers
(Pixabay)

> Nordic Nanovector delayed the readout from its phase 2b follicular lymphoma trial in response to slow patient enrollment. The delay moves the readout beyond when analysts at Jefferies expect the biotech’s current cash reserves to run dry. Release 

> PPF bought a 19.2% stake in CAR-T biotech Autolus. The Czech investment group owns most of another biotech, Sotio. Statement

> Lytix Biopharma appointed Øystein Rekdal as CEO. Rekdal replaces Edwin Klumper, who is taking early retirement. Release

Virtual Roundtable

ASCO Explained: Expert predictions and takeaways from the world's biggest cancer meeting

Join FiercePharma for our ASCO pre- and post-show webinar series. We'll bring together a panel of experts to preview what to watch for at ASCO. Cancer experts will highlight closely watched data sets to be unveiled at the virtual meeting--and discuss how they could change prescribing patterns. Following the meeting, we’ll do a post-show wrap up to break down the biggest data that came out over the weekend, as well as the implications they could have for prescribers, patients and drugmakers.

> Poxel shared detailed data from a Japanese phase 3 trial of imeglimin in Type 2 diabetics. Metavant has the rights to the drug in the U.S. and Europe. Statement 

> Theranexus enrolled the last subject in a phase 1b trial of its treatment of neurocognitive disorders related to Alzheimer's disease. Release 

> Ose Immunotherapeutics received a €5.4 million ($6 million) milestone payment in relation to its Boehringer Ingelheim-partnered SIRPa-antagonist and myeloid checkpoint inhibitor. Statement 

Suggested Articles

Inovio CEO J. Joseph Kim is undeterred by short sellers and other detractors who doubt his company can shuttle a COVID-19 DNA vaccine to market.

Adding entinostat to hormone therapy did not help patients with HR-positive, HER2-negative breast cancer live longer.

The data add to the evidence in support of the IL-6 drug ahead of a FDA decision to approve it in a rare disease served by Alexion’s Soliris.